Diagnostic algorithm for antineutrophil cytoplasmic antibody-associated systemic vasculitis

Diagnostic algorithm for antineutrophil cytoplasmic antibody-associated systemic vasculitis

Antineutrophil cytoplasm antibody (ANCA)-associated vasculitis (AAV) are rare autoimmune disorders and characterized by severe multiple organ lesions with a potential fatal outcome. AAV comprises granulomatosis with polyangiitis (GPA), microscopic polyangiitis (MPA) and eosinophilic granulomatosis w...

Full description

Bibliographic Details
Main Author:	T V Beketova
Format:	Article
Language:	Russian
Published:	"Consilium Medicum" Publishing house 2018-05-01
Series:	Терапевтический архив
Subjects:	antineutrophil cytoplasmic antibody systemic vasculitis anca-associated systemic vasculitis granulomatosis with polyangiitis microscopic polyangiitis eosinophilic granulomatosis with polyangiitis
Online Access:	https://ter-arkhiv.ru/0040-3660/article/viewFile/32729/pdf

Similar Items

Targeted proteomics reveals promising biomarkers of disease activity and organ involvement in antineutrophil cytoplasmic antibody-associated vasculitis
by: Jun Ishizaki, et al.
Published: (2017-09-01)

Nailfold videocapillaroscopy in antineutrophil cytoplasmic antibody–associated vasculitis
by: Megan M. Sullivan, et al.
Published: (2024-01-01)

Review of guideline for the management of ANCA-associated vasculitis, presented in 2021 by the American College of Rheumatology/Vasculitis Foundation
by: T. V. Beketova, et al.
Published: (2021-12-01)

THE 2016 EUROPEAN (EULAR/ERA-EDTA) RECOMMENDATIONS FOR THE DIAGNOSIS AND MANAGEMENT OF ANCA-ASSOCIATED SYSTEMIC VASCULITIS
by: T. V. Beketova
Published: (2017-03-01)

GRANULOMATOSIS WITH POLYANGIITIS, WHICH IS PATHOGENETICALLY ASSOCIATED WITH ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES: CLINICAL FEATURES
by: Tatiana Valentinovna Beketova
Published: (2012-12-01)

Childhood-Onset ANCA- Associated Vasculitis: single center experience from Central California
by: Deepika Singh, et al.
Published: (2023-07-01)

Antineutrophil cytoplasmic antibody-associated vasculitis, update on molecular pathogenesis, diagnosis, and treatment
by: Arman F, et al.
Published: (2018-11-01)

CLINICAL AND LABORATORY FEATURES OF ANCA ASSOCIATED VASCULITIS: EXPERIENCE AT A TERTIARY CARE HOSPITAL IN LAHORE, PAKISTAN
by: Muhammad Zeeshan Aslam, et al.
Published: (2021-02-01)

Update of Management of ANCA-Associated Vasculitis
by: Hoi San Tang, et al.
Published: (2021-12-01)

Eosinophils in anti-neutrophil cytoplasmic antibody associated vasculitis
by: Thomas Hellmark, et al.
Published: (2019-03-01)

Individualization of the ANCA associated vasculitis treatment
by: Zbigniew Zdrojewski
Published: (2014-09-01)

Microscopic polyangiitis associated with antineutrophil cytoplasmic antibodies: Clinical features
by: T V Beketova
Published: (2015-05-01)

THE 2015 INTERNATIONAL GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS
by: T. V. Beketova, et al.
Published: (2016-07-01)

Current approaches to diagnosing and treating eosinophilic granulomatosis with polyangiitis: The 2015 international guidelines
by: T V Beketova, et al.
Published: (2016-05-01)

CLINICAL AND LABORATORY FEATURES OF ANCA ASSOCIATED VASCULITIS: EXPERIENCE AT A TERTIARY CARE HOSPITAL IN LAHORE, PAKISTAN
by: Muhammad Zeeshan Aslam, et al.
Published: (2021-02-01)

Natural Killer Cells in Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - A Review of the Literature
by: Sina Fuchs, et al.
Published: (2022-01-01)

Serum B cell activating factor (BAFF) as a biomarker for induction of remission with rituximab in ANCA-associated vasculitis
by: Kazuyuki Tsuboi, et al.
Published: (2022-10-01)

Primary Vasculitis in Childhood: GPA and MPA in Childhood
by: Mehul P. Jariwala, et al.
Published: (2018-08-01)

Recommendations of the Brazilian Society of Rheumatology for the induction therapy of ANCA-associated vasculitis
by: Alexandre Wagner Silva de Souza, et al.

Eosinophilic Granulomatosis with Polyangiitis Manifesting as Recurrent Nasal Polyps and Hemorrhagic Necrotic Bullae: A Rare Disease Successfully Treated with Azathioprine
by: Abdulaziz Alotaibi, et al.
Published: (2019-02-01)

Ophthalmological involement and laboratory changes in patients with ANCA-associated vasculitis and polyarteritis nodosa
by: O. Iaremenko, et al.
Published: (2022-12-01)

THE ONSET OF ANCA-ASSOCIATED SYSTEMIC VASCULITIS MASKING RHEUMATOID ARTHRITIS
by: N. F. Frolova, et al.
Published: (2016-02-01)

Treating Patients With ANCA-Associated Vasculitis and Very Severe Renal Injury With an Intensified B Cell Depletion Therapy: Comparison With a Control Cohort Receiving a Conventional Therapy
by: Dario Roccatello, et al.
Published: (2022-03-01)

The course and outcomes of COVID-19 in patients with ANCA-associated systemic vasculitis, receiving biological therapy (Rituximab, Mepolizumab): The results of the first 8 months of the pandemic
by: T. V. Beketova, et al.
Published: (2021-03-01)

Successful total hip arthroplasty in patients with anca-associated systemic vasculitis
by: T. V. Beketova, et al.
Published: (2019-11-01)

Granulomatosis with polyangiitis: An atypical initial presentation
by: Catarina Vilaça Pereira, et al.
Published: (2022-01-01)

Granulomatosis (Wegener's granulomatosis) with polyangiitis presented as pulmonary manifestation: a case report
by: Qusay Jummaa Lazim, et al.
Published: (2020-11-01)

CLINICAL AND RADIOLOGICAL CHARACTERISTICS OF ANCA-ASSOCIATED VASCULITIS: 7 YEARS OF EXPERIENCE IN DIAGNOSIS AND TREATMENT
by: L. M. Kudelya, et al.
Published: (2020-03-01)

Trend and Geographic Disparities in the Mortality Rates of Primary Systemic Vasculitis in the United States from 1999 to 2019: A Population-Based Study
by: Alicia Rodriguez-Pla, et al.
Published: (2021-04-01)

Association of COVID‐19 antigenicity with the development of antineutrophilic cytoplasmic antibody vasculitis
by: Jamie R. Felzer, et al.
Published: (2022-01-01)

Health-related quality of life in ANCA-associated vasculitis and item generation for a disease-specific patient-reported outcome measure
by: Robson JC, et al.
Published: (2018-01-01)

Induction Therapy in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis with Renal Involvement: The Nephrologist's Point of View
by: Maurizio Salvadori, et al.
Published: (2018-07-01)

Eosinophilic Granulomatosis With Polyangiitis Presenting With Oral Granuloma as the Initial Symptom: A Case Report
by: Lirong Lin, et al.
Published: (2022-05-01)

Central Nervous System Involvement in ANCA-Associated Vasculitis: What Neurologists Need to Know
by: Yang Zheng, et al.
Published: (2019-01-01)

A Candidate Gene Approach to ANCA-Associated Vasculitis Reveals Links to the C3 and CTLA-4 Genes but not to the IL1-Ra And Fcγ-RIIa Genes
by: Ulf Persson, et al.
Published: (2013-12-01)

RUSSIAN EXPERIENCE WITH USING MONOCLONAL ANTIBODIES TO B-LYMPHOCYTES (RITUXIMAB) IN SYSTEMIC VASCULITIDES ASSOCIATED WITH NEUTROPHIL CYTOPLASMIC ANTIBODIES (PRELIMINARY RESULTS OF THE RUSSIAN REGISTER NORMA)
by: T. V. Beketova, et al.
Published: (2014-06-01)

Anti-neutrophil cytoplasmic antibodies in rheumatoid arthritis: two case reports and review of literature
by: Spoerl David, et al.
Published: (2012-12-01)

Clinical characteristics and long-term survival differences of the ANCA-associated vasculitis group: a cross-sectional study of 27 patients
by: Jolanta Dadonienė, et al.
Published: (2017-07-01)

Predictors of relapse in granulomatosis with polyangiitis: a multi-center study
by: Sara Safari, et al.
Published: (2022-10-01)

Granulomatosis with Polyangiitis (Wegener Granulomatosis) Mimicking Infective Endocarditis
by: Imène Rachdi, et al.
Published: (2014-10-01)